Company news
Optiscan Imaging Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Optiscan Signs MOU with University of Minnesota
August 18, 2024
OIL June 2024 Quarterly Report and Appendix 4C
July 31, 2024
Optiscan Delivers Major Milestone in Telepathology Platform
July 28, 2024
Optiscan Receives Ethical Clearance for Breast Cancer Study
July 14, 2024
Optiscan 2024 Roadshow Presentation
June 30, 2024
Optiscan Reveals InVue Imaging Device for Precision Surgery
June 3, 2024
Optiscan Webinar Investor Presentation
May 16, 2024
Optiscan Signs Know-How Agreement with Mayo Clinic
May 12, 2024
OIL March 2024 Quarterly Report and Appendix 4C
April 30, 2024
Optiscan appoints US Clinical & Regulatory Heads
April 2, 2024
OIL Appendix 4D and 31 December 2023 Half-year report
February 22, 2024
Optiscan receives $3 million CRC-P Industry Grant
February 13, 2024
OIL December 2023 Quarterly Report and Appendix 4C
January 30, 2024
Response to ASX Price Query
November 14, 2023
OIL September 2023 Quarterly Report and Appendix 4C
October 31, 2023
Optiscan Correlates with Histology in Breast Study
September 19, 2023
OIL Appendix 4E and June 2023 Annual Report
August 30, 2023
Optiscan Achieves Telepathology Milestone
August 14, 2023
OIL June 2023 Quarterly Report and Appendix 4C
July 28, 2023
Entitlement Offer Results and Shortfall Announcement
July 12, 2023
Optiscan Launches Entitlement Offer to Raise $16.7M
May 30, 2023
Optiscan Entitlement Issue Prospectus
May 30, 2023
Trading Halt
May 25, 2023
OIL March 2023 Quarterly Report and Appendix 4C
April 28, 2023
Optiscan Platform Highly Accurate for Oral Cancer Diagnosis
March 13, 2023
Optiscan Intends to pursue De Novo Pathway for InVivage
March 2, 2023
OIL Appendix 4D and 31 December 2022 Half-year report
February 27, 2023
Optiscan partners with Prolucid to develop AI Algorithms
January 29, 2023
OIL December 2022 Quarterly Report and Appendix 4C
January 27, 2023
Optiscan Managing Director 2022 AGM Presentation
November 24, 2022
OIL September 2022 Quarterly Report and Appendix 4C
October 31, 2022
Optiscan Imaging Acquires Intellectual Property
October 24, 2022
Appendix 4E and 2022 Annual Report
August 31, 2022
Optiscan Submits FDA 510(k) Application for InVivage Device
August 21, 2022
OIL June 2022 Quarterly Report and Appendix 4C
July 29, 2022
Strategic Distribution Partnership - Additional Information
June 28, 2022
Optiscan announces Strategic Distribution Partner for China
June 26, 2022
OIL March 2022 Quarterly Report and Appendix 4C
April 29, 2022
Appendix 4D and 31 December 2021 Half-year report
February 24, 2022
OIL December 2021 Quarterly Report and Appendix 4C
January 31, 2022
2021 AGM Chairmans Address and MD Presentation
January 20, 2022
Appointment of Prof. Camile Farah as New CEO & Managing Director
January 16, 2022
Change of Managing Director
December 12, 2021
Completion of imaging for Melbourne Breast cancer trial
November 11, 2021
OIL September 2021 Quarterly Report and Appendix 4C
October 26, 2021
Receipt of R&D Tax Incentive Rebate
October 25, 2021
OIL FY21 Annual Results Presentation
August 30, 2021
Appendix 4E and 2021 Annual Report
August 30, 2021
OIL June 2021 Quarterly Report and Appendix 4C
July 29, 2021
Update on seeking United States FDA approval & market entry
May 31, 2021
Decks
The 5 newest of 38 decks. Every deck is listed under its year.
- Bell Potter Healthcare Conference (November 2026)
Conference · 11 slides · Nov 17, 2026
- Investor Presentation (December 2025)
Investor deck · 37 slides · Dec 4, 2025
- Shareholder Meeting (November 2025)
Shareholder meeting · 40 slides · Nov 14, 2025
- ASX SMIDcaps Conference, Sydney 2025
Conference · 22 slides · Sep 24, 2025
- Corporate Update (April 2025)
Corporate update · 26 slides · Apr 10, 2025